ClinConnect ClinConnect Logo
Search / Trial NCT06849050

The Influence of Acute Continuous Exercise and Adiposity on Appetite Hormones and Neural Correlates of Visual Food Cues

Launched by LOUGHBOROUGH UNIVERSITY · Feb 24, 2025

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Appetite Obesity Overweight F Mri Neural Correlates Exercise Oxyntomodulin

ClinConnect Summary

This clinical trial is studying how a single session of continuous walking or jogging affects appetite-related hormones and brain responses to food cues in people who are overweight or have obesity. The researchers want to see if exercise changes the levels of hormones that either increase or decrease appetite and how these changes relate to what people feel about their hunger and what they eat afterward.

To be eligible for the study, participants should be between 18 and 70 years old with a specific body mass index (BMI) and waist size, depending on their ethnic background. They need to be generally healthy, able to walk for an hour on a treadmill, and stable in their weight for the past three months. Participants will undergo a 45-minute MRI scan and will be asked to maintain their usual eating patterns during the study. It’s important to note that smokers, those with certain medical conditions, or anyone taking specific medications will not be able to participate. This trial is a great opportunity for individuals interested in understanding how exercise affects appetite and eating behaviors.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Body mass index (BMI) between 18.5 - 24.9 kg/m2 and a waist circumference of ≤ 88 cm for women, and ≤ 102 cm for men or a BMI between 25 - 40 kg/m2 and a waist circumference of \> 88 cm for women, and \> 102 cm for men. BMI and waist circumference thresholds vary amongst ethnicities. People with a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background are prone to central adiposity and their cardiometabolic risk occurs at a lower BMI. Therefore, the following BMI and waist circumference thresholds will be applied for people of South Asian, other Asian, Black African and African-Caribbean ethnicity: (1) BMI 18.5 kg/m2 to 23 kg/m2 and waist circumference of \< 90 cm for men and \< 80 cm for women; (2) BMI 23.1 kg/m2 to 40 kg/m2 and waist circumference of ≥ 90 cm for men and ≥ 80 cm for women.
  • Normally consumes three meals a day
  • Able to walk continuously for 1 hour on a treadmill
  • Weight stable for 3 months (\< 3kg change in weight)
  • Regular menstrual cycle for the last 6 months (people taking the combined contraceptive pill are eligible for the study)
  • Able to undergo a 45-minute MRI scan
  • Exclusion Criteria:
  • Smokers (vaping is considered smoking in this study)
  • Known medical conditions (e.g. diabetes, heart condition)
  • Taking any medication which may affect the study outcomes (e.g. liraglutide, semaglutide, insulin, steroids, anti-psychotics)
  • Clinically diagnosed eating disorder
  • Previous bariatric surgery (e.g. gastric bypass, gastric band, sleeve gastrectomy)
  • Food allergies or intolerances, or severe dislikes to study foods
  • Pregnant or breastfeeding
  • Have recently donated blood (within eight weeks of visits 2 and 3).

About Loughborough University

Loughborough University is a leading UK higher education institution renowned for its commitment to research excellence and innovation in various fields, including health and sports sciences. As a clinical trial sponsor, the university leverages its extensive expertise and state-of-the-art facilities to design and conduct robust clinical studies aimed at advancing medical knowledge and improving patient outcomes. With a focus on interdisciplinary collaboration, Loughborough University fosters partnerships with industry and healthcare organizations, ensuring that its research initiatives are both impactful and aligned with real-world health challenges.

Locations

Loughborough, , United Kingdom

Patients applied

0 patients applied

Trial Officials

David J Stensel

Principal Investigator

Loughborough University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported